Concepedia

Comparison of the Efficacy and Tolerability Profile of Liraglutide, a Once-Daily Human GLP-1 Analog, in Patients With Type 2 Diabetes ≥65 and <65 Years of Age: A Pooled Analysis from Phase III Studies

Bruce W. Bode, Jason Brett, A Falahati, Richard E. Pratley

˜The œAmerican journal of geriatric pharmacotherapy · 2011 · 62 citations · 28 references

DOI

Concepts

References

28

Global Prevalence of Diabetes

Sarah H. Wild, Gojka Roglić, Anders Green et al. · Diabetes Care · 2004 · 15.3K citations

, , +12

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

John B. Buse, Julio Rosenstock, Giorgio Sesti et al. · The Lancet · 2009 · 1.5K citations

, , +13

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Michael A. Nauck, Anders Frid, Kjeld Hermansen et al. · Diabetes Care · 2008 · 1.1K citations · Full text

, , +17

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

Alan J. Garber, Robert R. Henry, Robert E. Ratner et al. · The Lancet · 2008 · 1.1K citations

, , +13

Incretin Effects of Increasing Glucose Loads in Man Calculated from Venous Insulin and C-Peptide Responses*

Michael A. Nauck, ERWIN HOMBERGER, E. G. Siegel et al. · The Journal of Clinical Endocrinology & Metabolism · 1986 · 875 citations

, , +17